The phrase "a substantially superior" is correct and usable in written English.
It can be used to describe something that is significantly better or of higher quality compared to something else.
Example: "The new model offers a substantially superior performance compared to its predecessor."
Alternatives: "a significantly better" or "a markedly improved".
The first thing to say is that The Promise is a substantially superior drama to Britz.
This strategy has been tested back to 1928 before the market crash and outperforms the S&P 500 by almost by nearly 3%, with a substantially superior risk return trade-off.
This "Follow the Fed" strategy of switching between large cap stocks and small cap stocks allows you to outperform the S&P 500 by almost 3% with a substantially superior risk return trade-off.
Rather, it seems to me that Lunarr only has a chance of gaining widespread adoption if it plays very nicely with these other online office tool providers and somehow maintains a substantially superior messaging system than those provided by office app providers themselves.
For GCTs of other sites, females had a substantially superior 5-year survival (P<0.001).
As has been previously suggested to be generally the case for protein-coding sequences [ 39], we found that the codon-position-specific model of rate heterogeneity among sites has a substantially superior fit to the data than the GTR + Γ + I model (see Table 1), and also supports a different consensus tree topology (see Figure 1).
The CSD has been demonstrated to successfully produce homogeneous stalk core samples in a repeatable manner with a throughput substantially superior to the currently available sampling methods.
The device that we have developed has been demonstrated to successfully produce homogeneous maize stalk core samples in a repeatable manner with a throughput substantially superior to the currently available sampling methods.
As hypothesized, a logistic regression model that utilized a panel of biomarkers had substantially superior performance to single biomarkers for differentiating sepsis patients with ARDS from those without ARDS as evaluated by ROC curve analysis.
In an open letter to Allergan shareholders, Valeant chief Michael Pearson said the company's new offer would be "substantially superior to an Allergan go-it-alone strategy".
In a letter Tuesday to Allergan shareholders, Valeant chief Michael Pearson said the company's new offer will be "substantially superior to an Allergan go-it-alone strategy".
